Ingevity (NGVT) Receives a Buy from Jefferies
Jefferies analyst maintained a Buy rating on Ingevity today and set a price target of $71.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Currently, the analyst consensus on Ingevity is a Moderate Buy with an average price target of $65.00.
Based on Ingevity’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $333.1 million and a net profit of $43.5 million. In comparison, last year the company earned a revenue of $376.9 million and had a GAAP net loss of $107.2 million
Read More on NGVT:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.